Equities
  • Price (EUR)24.20
  • Today's Change2.40 / 11.01%
  • Shares traded4.00k
  • 1 Year change-21.43%
  • Beta1.2313
Data delayed at least 15 minutes, as of Feb 06 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Omron Corp is a Japan-based company engaged in the manufacture and sale of electrical machinery and equipment, electronic application machinery and equipment, precision machinery and equipment, and medical machinery and equipment. It operates through five business segments. Industrial Automation Business (IAB) segment provides programmable controllers, motion control equipment, sensor equipment, industrial cameras and code readers, inspection equipment and others. Healthcare Business (HCB) segment provides electronic blood pressure monitors, nebulizers, low-frequency therapy devices, electrocardiographs and others. Social Systems Solutions & Services Business (SSB) segment engages in energy business, station service systems, traffic management systems and others. Device & Module Solutions Business (DMB) segment provides relays, switches, connectors and others. Data Solutions Business (DSB) segment engages in data healthcare business, corporate health business, and other businesses.

  • Revenue in JPY (TTM)836.34bn
  • Net income in JPY23.43bn
  • Incorporated1948
  • Employees26.61k
  • Location
    Omron CorpOmron Kyoto Center BldgShiokoji-dori Horikawa-higashiiriShimogyo-kuKYOTO-SHI 600-8530JapanJPN
  • Phone+81 753447000
  • Fax+81 753447001
  • Websitehttps://www.omron.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
6645:TYO since
announced
Transaction
value
iCARE Co LtdDeal completed18 Sep 202518 Sep 2025Deal completed13.19%--
Data delayed at least 15 minutes, as of Feb 06 2026 06:30 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.